Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 2
1985 1
1989 2
1990 2
1991 3
1992 1
1993 7
1994 2
1995 6
1996 8
1997 3
1998 6
1999 5
2000 8
2001 6
2002 9
2003 9
2004 6
2005 16
2006 12
2007 16
2008 19
2009 13
2010 20
2011 11
2012 15
2013 12
2014 14
2015 22
2016 11
2017 24
2018 20
2019 23
2020 15
2021 20
2022 14
2023 18
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

381 results

Results by year

Filters applied: . Clear all
Page 1
Saccharomyces boulardii: What Makes It Tick as Successful Probiotic?
Pais P, Almeida V, Yılmaz M, Teixeira MC. Pais P, et al. J Fungi (Basel). 2020 Jun 4;6(2):78. doi: 10.3390/jof6020078. J Fungi (Basel). 2020. PMID: 32512834 Free PMC article. Review.
Saccharomyces boulardii is a probiotic yeast often used for the treatment of GI tract disorders such as diarrhea symptoms. It is genetically close to the model yeast Saccharomyces cerevisiae and its classification as a distinct species or a S. cerevisi …
Saccharomyces boulardii is a probiotic yeast often used for the treatment of GI tract disorders such as diarrhea sympto …
Impact of Saccharomyces boulardii CNCM I-745 on Bacterial Overgrowth and Composition of Intestinal Microbiota in Diarrhea-Predominant Irritable Bowel Syndrome Patients: Results of a Randomized Pilot Study.
Bustos Fernández LM, Man F, Lasa JS. Bustos Fernández LM, et al. Dig Dis. 2023;41(5):798-809. doi: 10.1159/000528954. Epub 2023 Jan 11. Dig Dis. 2023. PMID: 36630947 Clinical Trial.
BACKGROUND: Small intestinal bacterial overgrowth (SIBO) is associated with diarrhea-predominant irritable bowel syndrome (IBS-D). Probiotics like Saccharomyces boulardii CNCM I-745 (Sb) may be efficacious in balancing the microbiota. ...Interestingly, F. pra …
BACKGROUND: Small intestinal bacterial overgrowth (SIBO) is associated with diarrhea-predominant irritable bowel syndrome (IBS-D). Pr …
Systematic review and meta-analysis of Saccharomyces boulardii in adult patients.
McFarland LV. McFarland LV. World J Gastroenterol. 2010 May 14;16(18):2202-22. doi: 10.3748/wjg.v16.i18.2202. World J Gastroenterol. 2010. PMID: 20458757 Free PMC article. Review.
This article reviews the evidence for efficacy and safety of Saccharomyces boulardii (S. boulardii) for various disease indications in adults based on the peer-reviewed, randomized clinical trials and pre-clinical studies from the published medical literature …
This article reviews the evidence for efficacy and safety of Saccharomyces boulardii (S. boulardii) for various disease …
Efficacy and safety of Saccharomyces boulardii for acute diarrhea.
Feizizadeh S, Salehi-Abargouei A, Akbari V. Feizizadeh S, et al. Pediatrics. 2014 Jul;134(1):e176-91. doi: 10.1542/peds.2013-3950. Pediatrics. 2014. PMID: 24958586 Review.
BACKGROUND AND OBJECTIVE: The efficacy of Saccharomyces boulardii for treatment of childhood diarrhea remains unclear. ...CONCLUSIONS: This review and meta-analysis show that S. boulardii is safe and has clear beneficial effects in children who have ac …
BACKGROUND AND OBJECTIVE: The efficacy of Saccharomyces boulardii for treatment of childhood diarrhea remains unclear. …
Probiotics.
Williams NT. Williams NT. Am J Health Syst Pharm. 2010 Mar 15;67(6):449-58. doi: 10.2146/ajhp090168. Am J Health Syst Pharm. 2010. PMID: 20208051 Review.
SUMMARY: Probiotics are live nonpathogenic microorganisms administered to improve microbial balance, particularly in the gastrointestinal tract. They consist of Saccharomyces boulardii yeast or lactic acid bacteria, such as Lactobacillus and Bifidobacterium species, …
SUMMARY: Probiotics are live nonpathogenic microorganisms administered to improve microbial balance, particularly in the gastrointestinal tr …
Effectiveness and safety of Saccharomyces boulardii for acute infectious diarrhea.
Dinleyici EC, Eren M, Ozen M, Yargic ZA, Vandenplas Y. Dinleyici EC, et al. Expert Opin Biol Ther. 2012 Apr;12(4):395-410. doi: 10.1517/14712598.2012.664129. Epub 2012 Feb 16. Expert Opin Biol Ther. 2012. PMID: 22335323 Review.
Regarding the treatment of acute diarrhea, a few probiotics including Saccharomyces boulardii seem to be promising therapeutic agents. ...This review describes the effects of S. boulardii on the duration of diarrhea, the risk of diarrhea …
Regarding the treatment of acute diarrhea, a few probiotics including Saccharomyces boulardii seem to be promising ther …
Saccharomyces boulardii CNCM I-745: A Non-bacterial Microorganism Used as Probiotic Agent in Supporting Treatment of Selected Diseases.
Kaźmierczak-Siedlecka K, Ruszkowski J, Fic M, Folwarski M, Makarewicz W. Kaźmierczak-Siedlecka K, et al. Curr Microbiol. 2020 Sep;77(9):1987-1996. doi: 10.1007/s00284-020-02053-9. Epub 2020 May 29. Curr Microbiol. 2020. PMID: 32472262 Free PMC article. Review.
The yeast Saccharomyces boulardii CNCM I-745 is a unique, non-bacterial microorganism classified as a probiotic agent. In this review article, at first, we briefly summarized the mechanisms responsible for its probiotic properties, e.g. adhesion to and elimination o …
The yeast Saccharomyces boulardii CNCM I-745 is a unique, non-bacterial microorganism classified as a probiotic agent. In this …
Clostridium difficile Colitis Prevention and Treatment.
Dinleyici M, Vandenplas Y. Dinleyici M, et al. Adv Exp Med Biol. 2019;1125:139-146. doi: 10.1007/5584_2018_322. Adv Exp Med Biol. 2019. PMID: 30689174 Review.
Clostridium difficile (C. diff) is the most common causative agent of antibiotic-associated diarrhea and colitis. This spore-forming, obligate anaerobic, gram-positive bacillus is becoming responsible for an increasing number of infections worldwide, both in community and …
Clostridium difficile (C. diff) is the most common causative agent of antibiotic-associated diarrhea and colitis. This spore-forming, …
[Saccharomyces boulardii in the treatment and prevention of antibiotic-associated diarrhea].
Micklefield G. Micklefield G. MMW Fortschr Med. 2014 Apr 17;156 Suppl 1:18-22. MMW Fortschr Med. 2014. PMID: 24930328 Review. German.
BACKGROUND: Antibiotic-associated diarrhea (AAD) is the most frequent side effect of antibiotic therapy. ...Therapy is symptomatic, antidiarrheal drugs like Saccharomyces boulardii are the therapy of choice. METHOD: Available studies on S. boulardii in …
BACKGROUND: Antibiotic-associated diarrhea (AAD) is the most frequent side effect of antibiotic therapy. ...Therapy is symptomatic, a …
Approach to probiotics in pediatrics: the role of Lactobacillus rhamnosus GG.
Boggio Marzet C, Burgos F, Del Compare M, Gerold I, Tabacco O, Vinderola G. Boggio Marzet C, et al. Arch Argent Pediatr. 2022 Feb;120(1):e1-e7. doi: 10.5546/aap.2022.eng.e1. Epub 2021 Dec 14. Arch Argent Pediatr. 2022. PMID: 35068121 Free article. Review. English, Spanish.
Certain probiotics have demonstrated to be effective in acute diarrhea and antibiotic-associated diarrhea. L. rhamnosus GG and Saccharomyces boulardii may shorten their duration and symptoms. ...
Certain probiotics have demonstrated to be effective in acute diarrhea and antibiotic-associated diarrhea. L. rhamnosus GG and …
381 results